Sinovac’s Covid-19 vaccine is one of two being considered by the WHO for ‘emergency use listing’. Photo: Xinhua Sinovac’s Covid-19 vaccine is one of two being considered by the WHO for ‘emergency use listing’. Photo: Xinhua
Sinovac’s Covid-19 vaccine is one of two being considered by the WHO for ‘emergency use listing’. Photo: Xinhua

China’s Sinopharm, Sinovac Covid-19 vaccines assessed by WHO for emergency use

  • WHO reviews two Chinese vaccines for ‘emergency use listing’ status, which could expedite their approval by countries’ regulators
  • It has received trial data from the companies and a decision could be made by March at the earliest

Topic |   Coronavirus pandemic
Sinovac’s Covid-19 vaccine is one of two being considered by the WHO for ‘emergency use listing’. Photo: Xinhua Sinovac’s Covid-19 vaccine is one of two being considered by the WHO for ‘emergency use listing’. Photo: Xinhua
Sinovac’s Covid-19 vaccine is one of two being considered by the WHO for ‘emergency use listing’. Photo: Xinhua
READ FULL ARTICLE